Clinical dilemma of contradictory HER2 results in breast cancer resolved by microarrays

Kotze K. J.; Murray E.; Lukhoff H. K.; Grant K.

首页> 外文期刊>The Breast : >Clinical dilemma of contradictory HER2 results in breast cancer resolved by microarrays

【24h】

Clinical dilemma of contradictory HER2 results in breast cancer resolved by microarrays

机译：HER2矛盾的临床困境导致微阵列化解决乳腺癌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast :》 |2015年第1期|共1页
作者
Kotze K. J.; Murray E.; Lukhoff H. K.; Grant K.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical dilemma of contradictory HER2 results in breast cancer resolved by microarrays [J] . Kotze K. J., Murray E., Lukhoff H. K., The Breast : . 2015,第Suppla1期

机译：HER2矛盾的临床困境导致微阵列化解决乳腺癌
2. Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers [J] . Singh Kamaljeet, Tantravahi Umadevi, Lomme Michele M., Breast cancer research and treatment. . 2016,第3期

机译：更新的2013年美国病理学家学院/美国临床肿瘤学会（CAP / ASCO）对人表皮生长因子受体2（HER2）荧光原位杂交（FISH）检测的指南建议增加了HER2阳性和HER2模棱两可的乳腺癌病例; 836例浸润性乳腺癌HER2 FISH结果的回顾性研究
3. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium [J] . Angela Cox, Annegien Broeks, Antoinette Hollestelle, The Journal of Pathology: Clinical Research . 2015,第1期

机译：乳腺癌协会联合会在乳腺癌组织微阵列中对ER，PR，HER2，CK5 / 6和EGFR进行自动评分的表现
4. Identifying High-Risk Breast Cancer Patients Using Microarray and Clinical Data [C] . Azni Nasuha Ngisa, Ong Huey Fang IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：使用微阵列和临床数据鉴定高危乳腺癌患者
5. Molecular characterization and clinical implementation of breast cancer genomics using massive parallel sequencing and microarray. [D] . Zhao, Wei. 2014

机译：使用大规模平行测序和微阵列的乳腺癌基因组学的分子表征和临床实施。
6. Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer [O] . Yun Gyoung Kim, Yi Na Yoon, Hyang Suk Choi, 2018

机译：HER2阴性乳腺癌细胞中的乳腺癌干细胞有助于HER2介导的放射抗性和分子亚型转化：复发性HER2阴性乳腺癌中血清HER2的临床意义
7. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium [O] . Howat, William J., Blows, Fiona M., Provenzano, Elena, 2015

机译：乳腺癌协会联合会在乳腺癌组织微阵列中对ER，PR，HER2，CK5 / 6和EGFR进行自动评分的表现

Clinical dilemma of contradictory HER2 results in breast cancer resolved by microarrays

著录项

相似文献

相关主题

期刊订阅